David A Elliott1, Nima Nabavizadeh2, Jeanna L Romer2, Yiyi Chen3, John M Holland2. 1. Department of Radiation Medicine, Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA. elliotda@ohsu.edu. 2. Department of Radiation Medicine, Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA. 3. Department of Public Health & Preventive Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Abstract
PURPOSE: The purpose of the study was to better understand why patients with history of head and neck cancer (HNC) treated with radiotherapy are using medical marijuana (MM). METHODS: Established HNC quality of life questionnaires and our own MM quality of life questionnaire were sent to 15 HNC patients treated at our institution who reported using MM. Patients are clinically disease free and currently using MM to manage long-term side effects after curative HNC treatment. RESULTS: There was a 100 % response rate. Median time from treatment was 45 months (21-136 months). Most patients smoked marijuana (12 patients), while others reported ingestion (4 patients), vaporizing (3 patients), and use of homemade concentrated oil (1 patient). Six patients reported prior recreational marijuana use before diagnosis. MM provided benefit in altered sense, weight maintenance, depression, pain, appetite, dysphagia, xerostomia, muscle spasm, and sticky saliva. CONCLUSIONS: HNC patients report MM use to help with long-term side effects of radiotherapy.
PURPOSE: The purpose of the study was to better understand why patients with history of head and neck cancer (HNC) treated with radiotherapy are using medical marijuana (MM). METHODS: Established HNC quality of life questionnaires and our own MM quality of life questionnaire were sent to 15 HNC patients treated at our institution who reported using MM. Patients are clinically disease free and currently using MM to manage long-term side effects after curative HNC treatment. RESULTS: There was a 100 % response rate. Median time from treatment was 45 months (21-136 months). Most patients smoked marijuana (12 patients), while others reported ingestion (4 patients), vaporizing (3 patients), and use of homemade concentrated oil (1 patient). Six patients reported prior recreational marijuana use before diagnosis. MM provided benefit in altered sense, weight maintenance, depression, pain, appetite, dysphagia, xerostomia, muscle spasm, and sticky saliva. CONCLUSIONS: HNC patients report MM use to help with long-term side effects of radiotherapy.
Entities:
Keywords:
Head and neck squamous cell carcinoma; Medical cannabis and medical marijuana; Quality of life; Questionnaire; Radiotherapy and chemoradiotherapy
Authors: Frederike K Engels; Floris A de Jong; Ron H J Mathijssen; Joëlle A Erkens; Ron M Herings; Jaap Verweij Journal: Eur J Cancer Date: 2007-10-31 Impact factor: 9.162
Authors: A Trotti; D J Johnson; C Gwede; L Casey; B Sauder; A Cantor; J Pearlman Journal: Int J Radiat Oncol Biol Phys Date: 1998-09-01 Impact factor: 7.038
Authors: E Hammerlid; K Bjordal; M Ahlner-Elmqvist; M Jannert; S Kaasa; M Sullivan; T Westin Journal: Otolaryngol Head Neck Surg Date: 1997-06 Impact factor: 3.497
Authors: K Bjordal; A de Graeff; P M Fayers; E Hammerlid; C van Pottelsberghe; D Curran; M Ahlner-Elmqvist; E J Maher; J W Meyza; A Brédart; A L Söderholm; J J Arraras; J S Feine; H Abendstein; R P Morton; T Pignon; P Huguenin; A Bottomly; S Kaasa Journal: Eur J Cancer Date: 2000-09 Impact factor: 9.162
Authors: K Bjordal; E Hammerlid; M Ahlner-Elmqvist; A de Graeff; M Boysen; J F Evensen; A Biörklund; J R de Leeuw; P M Fayers; M Jannert; T Westin; S Kaasa Journal: J Clin Oncol Date: 1999-03 Impact factor: 44.544
Authors: Daniel J Cobaugh; Carl Gainor; Cynthia L Gaston; Tai C Kwong; Barbarajean Magnani; Mary Lynn McPherson; Jacob T Painter; Edward P Krenzelok Journal: Am J Health Syst Pharm Date: 2014-09-15 Impact factor: 2.637
Authors: N P Nguyen; C C Moltz; C Frank; P Vos; H J Smith; U Karlsson; S Dutta; F A Midyett; J Barloon; S Sallah Journal: Ann Oncol Date: 2004-03 Impact factor: 32.976
Authors: Han Zhang; Michael Xie; Stuart D Archibald; B Stanley Jackson; Michael K Gupta Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-11-01 Impact factor: 6.223
Authors: Elizabeth K Do; Albert J Ksinan; Sunny Jung Kim; Egidio G Del Fabbro; Bernard F Fuemmeler Journal: Cancer Date: 2021-07-20 Impact factor: 6.860
Authors: Michael Xie; Michael K Gupta; Stuart D Archibald; B Stanley Jackson; James Edward Massey Young; Han Zhang Journal: J Otolaryngol Head Neck Surg Date: 2018-11-22
Authors: Gehad Mohamed Tawfik; Mohammad Rashidul Hashan; Abdelaziz Abdelaal; Thuan Minh Tieu; Nguyen Tien Huy Journal: Trop Med Health Date: 2019-05-24
Authors: Billy Vinette; José Côté; Ali El-Akhras; Hazar Mrad; Gabrielle Chicoine; Karine Bilodeau Journal: BMC Cancer Date: 2022-03-24 Impact factor: 4.430